104 related articles for article (PubMed ID: 8642858)
21. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W
Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
[TBL] [Abstract][Full Text] [Related]
22. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
Steube KG; Jadau A; Teepe D; Drexler HG
Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
24. Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program.
Debatin KM; Krammer PH
Leukemia; 1995 May; 9(5):815-20. PubMed ID: 7539514
[TBL] [Abstract][Full Text] [Related]
25. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
[TBL] [Abstract][Full Text] [Related]
26. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
27. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
28. BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.
Pocock CF; Malone M; Booth M; Evans M; Morgan G; Greil J; Cotter FE
Br J Haematol; 1995 Aug; 90(4):855-67. PubMed ID: 7669664
[TBL] [Abstract][Full Text] [Related]
29. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
30. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
32. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig WD
Blood; 2000 Jul; 96(1):297-306. PubMed ID: 10891465
[TBL] [Abstract][Full Text] [Related]
34. [Expression of bcl-2 in acute leukemia patients and its significance].
Jian ZF; Zhou YH; Chen FP
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):397-8. PubMed ID: 12206015
[TBL] [Abstract][Full Text] [Related]
35. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
Baghdassarian N; Bertrand Y; Ffrench P; Duhaut P; Bryon PA; Ffrench M
Br J Haematol; 2000 Apr; 109(1):109-16. PubMed ID: 10848789
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
Amirghofran Z; Daneshbod Y; Gholijani N
Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
38. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
39. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.
Campos L; Rouault JP; Sabido O; Oriol P; Roubi N; Vasselon C; Archimbaud E; Magaud JP; Guyotat D
Blood; 1993 Jun; 81(11):3091-6. PubMed ID: 7684624
[TBL] [Abstract][Full Text] [Related]
40. Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia.
Narayan S; Chandra J; Sharma M; Naithani R; Sharma S
Hematology; 2007 Feb; 12(1):39-43. PubMed ID: 17364991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]